Kura Oncology Inc (KURA)
10.05
-5.86
(-36.83%)
USD |
NASDAQ |
Nov 21, 16:00
10.04
-0.01
(-0.10%)
After-Hours: 20:00
Kura Oncology Price to Book Value: 1.844 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 2.920 |
| November 19, 2024 | 2.929 |
| November 18, 2024 | 2.943 |
| November 15, 2024 | 2.921 |
| November 14, 2024 | 3.026 |
| November 13, 2024 | 3.257 |
| November 12, 2024 | 3.408 |
| November 11, 2024 | 3.222 |
| November 08, 2024 | 3.244 |
| November 07, 2024 | 3.261 |
| November 06, 2024 | 3.274 |
| November 05, 2024 | 3.215 |
| November 04, 2024 | 3.268 |
| November 01, 2024 | 3.097 |
| October 31, 2024 | 3.068 |
| October 30, 2024 | 3.114 |
| October 29, 2024 | 3.185 |
| October 28, 2024 | 3.253 |
| October 25, 2024 | 3.212 |
| October 24, 2024 | 3.262 |
| October 23, 2024 | 3.123 |
| October 22, 2024 | 3.187 |
| October 21, 2024 | 3.247 |
| October 18, 2024 | 3.302 |
| October 17, 2024 | 3.319 |
| Date | Value |
|---|---|
| October 16, 2024 | 3.352 |
| October 15, 2024 | 3.341 |
| October 14, 2024 | 3.314 |
| October 11, 2024 | 3.409 |
| October 10, 2024 | 3.346 |
| October 09, 2024 | 3.361 |
| October 08, 2024 | 3.332 |
| October 07, 2024 | 3.282 |
| October 04, 2024 | 3.310 |
| October 03, 2024 | 3.336 |
| October 02, 2024 | 3.394 |
| October 01, 2024 | 3.524 |
| September 30, 2024 | 3.585 |
| September 27, 2024 | 3.210 |
| September 26, 2024 | 3.200 |
| September 25, 2024 | 3.218 |
| September 24, 2024 | 3.259 |
| September 23, 2024 | 3.323 |
| September 20, 2024 | 3.445 |
| September 19, 2024 | 3.466 |
| September 18, 2024 | 3.331 |
| September 17, 2024 | 3.315 |
| September 16, 2024 | 3.432 |
| September 13, 2024 | 3.433 |
| September 12, 2024 | 3.270 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.309
Minimum
Oct 23 2023
8.967
Maximum
Dec 11 2020
2.821
Average
2.457
Median
Price to Book Value Benchmarks
| AIM ImmunoTech Inc | 4.627 |
| Perspective Therapeutics Inc | 0.6153 |
| Protalix BioTherapeutics Inc | 3.791 |
| Electromed Inc | 5.682 |
| Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| Price | 10.05 |
| Earnings Yield | -23.48% |
| Market Cap | 781.53M |